US Drug Advertising Faces New Scrutiny Under Healthcare Reform
The United States stands alone as the only nation where direct-to-consumer (DTC) pharmaceutical advertising is standard practice. While the industry spends an estimated $8 to $10 billion annually on these campaigns, a growing bipartisan movement in Congress and state legislatures is now pushing to restrict or eliminate these advertisements, citing concerns over rising healthcare costs … Read more